Revivo Therapeutics

📍 Durham, United States🗓 Founded 2016👥 7 employees💰 Last funded Nov 2020
Biotechnology🌐 revivotherapeutics.com
Website LinkedIn
Clinical stage biotechnology company developing a new class of cognitive enhancing small molecules targeting cognitive decline. Our first drug candidate RIV-5061 targets the treatment of Mild Cognitive Impariment. We are in the process of raising funding for Phase 1/1b clinical trials.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Revivo Therapeutics?
Revivo Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Revivo Therapeutics last raise funding?
The most recent investment in Revivo Therapeutics recorded on gritt.io was in November 2020.
When was Revivo Therapeutics founded?
Revivo Therapeutics was founded in 2016.
What industry is Revivo Therapeutics in?
Revivo Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Revivo Therapeutics based?
Revivo Therapeutics is headquartered in Durham, United States.